Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform (GlobeNewswire)
"Todos Medical...announced that it has received two Notices of Allowance from the United States Patent & Trademark Office (USPTO) for patent applications covering the Company’s Total Biochemical Infrared Analysis (TBIA) Fourier Transformed Infrared (FTIR) pan-cancer blood diagnostics platform. The Notices of Allowance are for patent applications entitled 1) 'Infrared (IR) Spectroscopy System' and 2) 'Infrared Analysis of Benign Tumors'....The key allowed claim for Infrared (IR) Spectroscopy System patent application was surrounding the system of collecting blood, obtaining FTIR spectrum from peripheral blood lymphocytes, and an output unit, configured to generate an output indicative of the presence of a solid tumor."